Veracode Advances Application Risk Management with Innovations for Comprehensive Risk Visibility and Software Supply Chain Security
22.4.2025 13:50:00 CEST | Business Wire | Press Release
Veracode, a global leader in application risk management, today unveiled new capabilities offering proactive risk mitigation and automated security at enterprise scale. With software supply chain attacks and open-source vulnerabilities at an all-time high, enhanced Veracode Risk Manager (VRM) and an early access program for Veracode Package Firewall come at a critical juncture. The innovations represent a significant milestone in Veracode’s vision to deliver centralized risk visibility and secure development from the start.
“Security teams face immense pressure to combat evolving threats, while developers require the flexibility to innovate quickly,” said Derek Maki, Head of Product at Veracode. “Our latest Application Risk Management platform enhancements provide organizations with the tools to not just identify risks, but to trace them to their root cause and prevent them before they compromise the software supply chain—all without slowing down development.”
Veracode’s newest offerings address increasing risk from open-source vulnerabilities and untrusted sources, reinforcing its leadership in application security innovation. The offerings combine automation with detailed remediation guidance to enable frictionless workflows throughout the software development lifecycle.
Fortified Software Supply Chain Security with Veracode Package Firewall
With over 97 percent of applications leveraging open-source components, malicious or noncompliant packages expose organizations to serious security risk. Veracode Package Firewall, built on technology acquired from Phylum Inc., blocks unsafe dependencies before they enter an organization’s environment. The tool employs the Open Policy Agent (OPA), a universal standard for policy automation that enables automated enforcement to expedite governance, effectively preventing software supply chain risks at the earliest entry point. Veracode Package Firewall delivers:
- Proactive Risk Mitigation: Strengthened security posture, reduced attack surface, and lower operational costs through automation and early threat mitigation.
- Streamlined Security and Compliance: Faster time to market, simplified compliance reporting, and enhanced collaboration across security and development teams.
- Secure Developer Productivity: Improved efficiency and innovation, freeing up developers’ time to focus on building software.
Veracode Package Firewall is currently available to a subset of customers under early access and will be generally available in June 2025.
Intelligent and Contextualised Prioritization with Veracode Risk Manager
Security teams are overwhelmed with the volume of risk alerts, making it challenging to identify which vulnerabilities are the most critical. Veracode’s latest enhancements to VRM further strengthen its Application Security Posture Management (ASPM) capabilities, providing unified risk visibility, contextual prioritization, and automated threat management. Key new features include:
- Runtime Container Risk Context: Seamless integration with Kubernetes environments to enrich vulnerability findings with crucial runtime intelligence. This allows customers to prioritize remediation efforts by identifying which vulnerabilities exist in packages that are loaded and exposed in running containers, focusing on the most tangible risks to the business and providing continuous visibility into the application’s runtime posture.
- Advanced Labeling Capabilities: Precise control over security findings with highly customizable tags and classifications. This granular labeling directly streamlines remediation by enabling targeted filtering and the creation of role-specific risk views tailored to use cases that matter most to the business.
- Repository Tools: More seamless integration with repository tools to pinpoint the exact origin of vulnerabilities, identifying the root cause of risk. This direct line of sight accelerates root cause analysis and enables teams to address security flaws with greater speed and precision.
Veracode Risk Manager automates issue investigation and prioritization while facilitating real-time monitoring—crucial for evaluating and improving security posture across multi-cloud environments. These latest enhancements enable organizations to address risk more effectively, with improved precision, triaging, and control over findings from multiple environments. Runtime Container Risk Context and Repository Tools are available now, and Advanced Labeling Capabilities will be coming soon.
See the Innovations Live at RSAC 2025
Veracode’s experts will be on site at RSAC Conference in San Francisco (April 28 - May 1, 2025) to showcase the company’s latest products. Visit booth #1243 for interactive demos and expert discussions on how to stay ahead of emerging threats and stop software supply chain attacks before they happen.
Learn more about Veracode’s products on the website.
About Veracode
Veracode is a global leader in Application Risk Management for the AI era. Powered by trillions of lines of code scans and a proprietary AI-assisted remediation engine, the Veracode platform offers adaptive software security and is trusted by organizations worldwide to build and maintain secure software from code creation to cloud deployment. Thousands of the world’s leading development and security teams use Veracode every second of every day to get accurate, actionable visibility of exploitable risk, achieve real-time vulnerability remediation, and reduce their security debt at scale. Veracode is a multi-award-winning company offering capabilities to secure the entire software development life cycle, including Veracode Fix, Static Analysis, Dynamic Analysis, Software Composition Analysis, Container Security, Application Security Posture Management, Malicious Package Detection, and Penetration Testing.
Learn more at www.veracode.com, on the Veracode blog, and on LinkedIn and X.
Copyright © 2025 Veracode, Inc. All rights reserved. Veracode is a registered trademark of Veracode, Inc. in the United States and may be registered in certain other jurisdictions. All other product names, brands or logos belong to their respective holders. All other trademarks cited herein are property of their respective owners.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250422270202/en/
Contacts
For more information, please contact:
Katy Gwilliam
kgwilliam@veracode.com
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 202624.10.2026 10:15:00 CEST | Press Release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from multiple differentiated investigational medicines across its priority solid tumor disease areas at the European Society for Medical Oncology (ESMO) Congress 2026 (October 23–27, Madrid). The presentations span gastrointestinal, lung, and breast cancers, and reflect the growing momentum of BeOne’s solid tumor franchise. Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “At ESMO, we are showing how our strategy of matching the right modality to disease biology is translating into meaningful clinical progress. Our GPC3 x 4-1BB bispecific antibody continues to be well tolerated and demonstrates durable activity with longer follow up in patients with heavily pre-treated hepatocellular carcinoma, while the first clinical data from our brain-penetrant PRMT5 inhibitor and CEA-targeting ADC expand our innovation in non-small cell lung cancer. Alongsi
Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press Release
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Society of Nephrology (ASN) Kidney Week 2026 in Denver, Colorado, and advancement of the povetacicept clinical research program in IgAN. Vertex will also host an investor event during ASN on October 23 at 6:15-7 p.m. MDT (8:15-9 p.m. EDT). Further details are below. Data being presented include a pre-specified Week 36 interim analysis of the ongoing Phase 3 RAINIER trial of povetacicept, an engineered fusion protein and dual inhibitor of the BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) cytokines, in immunoglobulin A nephropathy (IgAN). RAINIER met its primary endpoint, with povetacicept achieving a 52.0% reduction from baseline in proteinuria at Week 36 and a statistically significant and clinically meaningful 49.8% reduction versus placebo (
Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:19:00 CEST | Press Release
Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com
BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press Release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “Following the U.S. approval in August, these longer-term data provide further evidence supporting TEVIMBRA plus ZIIHERA and chemotherapy as the new standard of care in all first-line HER2-positive advanced gastroesophageal adenocarcinoma patients, regardless of PD-L1 sta
inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press Release
inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a leading Central Asian economy, this gives the companies a clear basis to assess autonomous ride-hailing in practice. The three companies will evaluate the technical, operational, regulatory and
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom